The DiaMedica Therapeutics Inc (DMAC) Stock expansion path ahead
Craig Hallum raised the price target for the DiaMedica Therapeutics Inc (NASDAQ:DMAC) stock to “a Buy”. The rating was released on April 24, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $27. The stock was initiated by ROTH Capital, who disclosed in […]
Analyzing DiaMedica Therapeutics Inc’s (DMAC) Stock earnings per share and revenue
Craig Hallum raised the price target for the DiaMedica Therapeutics Inc (NASDAQ:DMAC) stock to “a Buy”. The rating was released on April 24, 2024, according to finviz. The research report from Oppenheimer has initiated the stock to Outperform, with a price target set at $27. The stock was initiated by ROTH Capital, who disclosed in […]
